Search
Contact Us
Linkedin-in Twitter
Search
Contact Us
Linkedin-in Twitter

Our Team

 

Highly skilled management team with breadth of experience across all business functions

Dr Shailendra Singh

Dr Shailendra R Singh

Founder and Chief Executive Officer

Find out more
Dr Anushuya Tamang

Dr Anushuya Tamang

Study and Operations Director

Find out more
photo of Lara De Tomasi wearing a burnt orange blazer and white top

Dr Lara De Tomasi

Bioassay Study and Operations Manager

Find out more
Alex Timmis in a pale blue shirt

Dr Alex Timmis

Bioassay Study Manager

Find out more
Stuart Gibson

Stuart Gibson

Consultant Finance Director

Find out more
Anand Krishna

Anand Krishna

Senior Director, Customer Engagement

Find out more
Pier

Dr Pier Giorgio Amendola

Business Development Consultant (Europe)

Find out more

Request a consultation with Cellomatics Biosciences today

Our experienced team of in vitro laboratory scientists will work with you to understand your project and provide a bespoke project plan with a professional, flexible service and a fast turnaround time.

To request a consultation where we can discuss your exact requirements, please contact a member of the team.

Get in touch

Contact us

Cellomatics Biosciences Limited
10 Colwick Quays Business Park
Private Road No 2, Colwick            Nottingham NG4 2JY, UK

+44 (115) 865 4101
info@cellomaticsbio.com

Linkedin-in Twitter

Services

Newsletter sign-up

To receive our newsletter, please sign up here.
Sign up

Contact us

Cellomatics Biosciences Limited
10 Colwick Quays Business Park
Road No2, Colwick Nottingham NG4 2JY, UK

+44 (115) 865 4101
info@cellomaticsbio.com

Newsletter sign-up

To receive our newsletter, please sign up here.
Sign up
Linkedin-in Twitter

Dr Shailendra R Singh  

Founder and Chief Executive Officer

Shailendra Singh is an experienced life science research scientist with over 18 years’ academic and commercial experience in diagnostic, pharmaceutical and biotech/biomedical sectors.

Originally qualifying as a medical doctor specializing in immunology, he then went on to train as a Pathologist and Immunologist. This led to his appointment as a Laboratory Operations Manager for Thyrocare Technologies Ltd., one of the leading Diagnostic Laboratories in India. He then went on to complete his Master of Research and PhD in Molecular Medicine from University of Nottingham, UK.

With years of combined experience working as a Postdoctoral Research Scientist in UK-based universities and as a Senior Discovery Scientist with hVIVO Services Ltd, he then went on to establish his own company, Cellomatics BioSciences Ltd, a Nottingham (UK) based preclinical CRO laboratory.

Shailendra has a strong track record in the management of technical/research organisations to cGMP quality standards and in the identification/discovery and characterisation of targets for in vitro validation work.

He is the author of several scientific papers in peer-reviewed journals.

Linkedin-in

Dr Anushuya Tamang 

Study and Operations Director

Anushuya holds a PhD in Developmental Biology and Embryology, and M.Res in Cancer Biology from Nottingham Trent University, UK. Her PhD research focused on “The differential expression of Cancer Testis Antigens and 5-HT Receptors in Normotensive and Pre-eclamptic Placentae, and their role in trophoblast invasion”.

During her PhD, she also worked as a part-time Lecturer for Pharmacology and Bioscience Department at Nottingham Trent University.

She completed her MSc and BSc in Biotechnology from Bangalore University, India. Following her university studies, she worked as Senior Scientific Analyst at Molecular Connections for over a year. As Senior Scientific Analyst, her responsibilities included data curation/ mining of scientific research articles/patents for developing data banks for clients and web search engines. She was also responsible for regularly training junior analysts and for the quality assurance of the team.

She has more than 12 years of experience in molecular and cellular biology, as well as histology.

Linkedin-in

Dr Lara De Tomasi

Bioassay Study and Operations Manager

Lara is a geneticist and molecular biologist with over 9 years of experience working in biomedical sciences, 3 of which in the contract research industry.

Lara holds a MSc and MRes in Genetics and Molecular Biology from Sapienza University of Rome and Paris Diderot University respectively as well as a PhD in Genetics obtained at the research institute of rare genetic diseased Imagine Institute in Paris, complemented by a postdoctoral research in the Hearing Research Group at the University of Sheffield.

At the beginning of 2022, Lara joined Cellomatics Biosciences Ltd as a Senior Bioassay Scientist and in January 2024 she got promoted to her current role of Bioassay Study and Operations Manager. Leading a team of Scientists, her role involves overseeing the smooth execution of client projects across all therapeutic areas of the Cellomatics service portfolio, as well as ensuring the efficient run of the laboratory.

Linkedin-in

Dr Alex Timmis

Bioassay Study Manager

Alex is a molecular biologist with 4 years of experience in the life sciences contract research industry.

Alex holds an MSc in Infection, Immunity, and Human Disease as well as a PhD in Cell and Molecular Biology from the University of Leeds.

In 2021, he joined Cellomatics Biosciences Ltd as a Bioassay Scientist, quickly progressing to senior scientist, before his promotion to bioassay study manager in January 2024. Managing a team of 5 scientists, his role involves overseeing the smooth execution of client projects across all therapeutic areas of the Cellomatics service portfolio.  

Linkedin-in

Mr Stuart Gibson

Consultant Finance Director

Stuart has over 20 years experience as a FD/CFO working with growth companies in the life sciences and technology sectors. 

He joined Arakis Ltd in 2001 shortly after the company was formed and played a key role in the companies success, culminating in the sale of Arakis to the Japanese quoted pharma company Sosei for over £100M in 2006. Stuart was appointed to the Board of Sosei shortly after and raised further funding on the Tokyo stock market before leaving in 2008. From 2008 to 2015 he worked for ARKeX, a new technology company operating worldwide in the Oil & Gas services sector. During his tenure he lead contract negotiations with customers and business partners globally including North Africa, Middle East and China. 

In 2015 Stuart set up his own consultancy buisness, Brosnaich Ventures Ltd, and works with a small portfolio of life science companies, including Cellomatics, to provide financial and corporate management support.    

Linkedin-in

Anand Krishna

Senior Director, Customer Engagement

Anand has built a career for nearly 25 years in the Technology Consulting and Outsourcing sector. He began as a Product Architect in a VC funded start-up in Germany. He has since held a number of senior and executive leadership roles with Tier 1 Technology Systems Integrators such as Capgemini, covering Strategy, M&A, Sales and Marketing, Project Management and Operations. During these years, he has opened businesses with the likes of Google, Microsoft, Amazon, McDonald’s and Coca Cola and scaled them to multi-million dollar accounts. He has managed businesses that have served inter-governmental and non-profit agencies such as The UN and The World Bank.

Anand has worked across the US, UK, Europe, India, and the Far East. He has managed people from across a spectrum of ethnicities, nationalities, demographic cohorts, gender identities and cognitive strengths. He now spends time helping a portfolio of entrepreneurs to scale their businesses.

He lives in Surrey, England. He has a Bachelor’s Degree in Zoology from the University of Mumbai and he is a qualified Executive Coach from the Henley School of Business.

Linkedin-in

Dr Pier Giorgio Amendola

Business Development Consultant (Europe)

Pier is a molecular biologist with 15+ years of international experience in pharmaceutical drug development and the life sciences sector. He has held leadership roles in both biotech startups and established pharmaceutical companies, driving several drugs to clinical stages or IND submission.

An entrepreneur at heart, Pier founded LOXiPharm (oncology, Copenhagen) and served as Research Director at ONA Therapeutics (oncology, Barcelona). He is currently Entrepreneur in Residence for the EIC Tech to Market Venture Building Programme and a mentor in two startup acceleration programs.

Pier holds an MSc in Oncology from the Weizmann Institute of Science (Israel) and a PhD in Epigenetics and Cancer from the University of Copenhagen, complemented by postdoctoral research in metastasis and tumor microenvironment at BRIC, Denmark.

In 2024, he launched his consultancy, R&D Pharmacon, offering expertise in drug development, life sciences, and business development. Pier supports business development initiatives across Europe on behalf of Cellomatics.

Linkedin-in